Sign up to save your podcasts
Or
Share E133: Obinutuzumab for SLE (ALLEGORY)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E133: Obinutuzumab for SLE (ALLEGORY)
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece!
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2516150
Landing Page: https://ebrheum.com/
Substack: https://autoimmunedevreport.substack.com/
View all episodes
By Michael Putman
4.9
114114 ratings
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece!
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2516150
Landing Page: https://ebrheum.com/
Substack: https://autoimmunedevreport.substack.com/
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
503 Listeners
Mayo Clinic Talks
296 Listeners
Rheumnow Podcast
129 Listeners
The Curbsiders Internal Medicine Podcast
3,367 Listeners
Core IM | Internal Medicine Podcast
1,147 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
519 Listeners
ACR on Air
68 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
The Curious Clinicians
375 Listeners
Rheumatology For The Royal College
183 Listeners
Febrile
187 Listeners
ACR Journals On Air
19 Listeners
Talking Rheumatology Spotlight
6 Listeners